$BMY News and Market Events
Every $BMY story Market Flux has tracked.
- Most Active
Contineum Therapeutics Swings From 27% Premarket Gain to 34% Loss After Mixed Bristol Myers IPF Data
Contineum Therapeutics (NASDAQ: CTNM) shares surged roughly 27% in premarket trading on Monday, October 12, after Bristol Myers Squibb (NYSE: BMY) announced positive Phase 3 results for its…
- Top Mover
Leerink Partners Cuts Bristol-Myers Squibb to Market Perform, Slashes Price Target to $59 on Pipeline Doubt
Leerink Partners downgraded Bristol-Myers Squibb from Outperform to Market Perform on October 5, cutting its price target to $59 from $73. Analyst David Risinger cited growing skepticism…
- Market Flux Event
Trump Announces Drug Pricing Deals With Nine More Pharma Companies, Expanding Most Favored Nation Push
President Trump announced on August 31 that his administration has struck drug pricing agreements with nine additional pharmaceutical and biotech companies, committing them to sell…
- Market Flux Event
Eli Lilly Wins European Approval for Weight Loss Pill Foundayo as BMY Scores FDA Nod for Myeloma Drug
Eli Lilly secured the first European regulatory approval for its oral weight loss pill Foundayo in the United Kingdom, intensifying a direct battle with Novo Nordisk, whose oral Wegovy was…